Our last live virtual event of 2021: a quick scientific tea break with Communication Specialist Dr. Emma Gibbin-Lameira, is now available on demand! Watch as Dr. Gibbin-Lameira presents a powerful cytotoxicity case study showing Nanolive’s unique live cell-based testing and high content analysis in 96-well plate.

Specifically, Dr. Gibbin-Lameira has shown that:

Multiplexed quantitative descriptors of cell morphology and composition at both the population (field of view) and single cell level can be combined with high spatio-temporal images to evaluate drug responses in parallel, over long periods of time
It is possible to quantify dose-response effects of drugs on living cells in a multi-well set-up where different concentrations and different drugs can be tested in parallel.

Download Application Note

Read our latest news

Unlocking mitochondrial stress as a drug discovery readout

Feb 25, 2026 | News

Mitochondrial stress can act as an early warning biomarker for drug candidate toxicity and can appear hours before conventional cell viability results. Discover case study data demonstrating how mitochondrial stress can be used as an early warning biomarker for cytotoxicity prediction.

Trends in AI analysis for live cell imaging

Jan 19, 2026 | News

We review recent peer-reviewed studies that relied on noninvasive live-cell imaging to study immuno-oncology, cellular metabolism and disease progression in 2025, and share how advances in image analysis are supporting consistent interpretation of complex live-cell data in preclinical research.

2025’s Breakthroughs in AI-Driven Live Cell Analytics

Dec 19, 2025 | News

We look back at some of 2025’s major advances in AI-driven live cell analytics, from automated mitochondrial segmentation to dynamic EC50 profiling and next-generation T-cell insights. These breakthroughs bring deeper, label-free understanding to drug discovery and immuno-oncology.

More news